• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[α-干扰素治疗儿童慢性丙型肝炎]

[Alpha-interferon in the treatment of chronic hepatitis C in children].

作者信息

Cinquetti M, Marchi D

机构信息

Cattedra di Pediatria dell'Università-Divisione di Pediatria dell'Ospedale Civile Maggiore di Verona, Italia.

出版信息

Pediatr Med Chir. 1995 Nov-Dec;17(6):501-7.

PMID:8668583
Abstract

The hepatitis C virus is the main causative agent for sporadic as well as parenteral cases of non-A non-B hepatitis. Alpha interferon is a biologically active protein produced by B lymphocytes and monocytes which can be manufactured by recombinant DNA technology. Treatment of chronic hepatitis C with interferon in adults is associated with a sustained response in 20-25% of treated cases. First studies provide encouraging results for the use of interferon in the treatment of chronic hepatitis C in children, but controlled trials using this drug in a larger population of children are needed.

摘要

丙型肝炎病毒是散发性以及经肠外途径感染的非甲非乙型肝炎的主要病原体。α干扰素是一种由B淋巴细胞和单核细胞产生的生物活性蛋白,可通过重组DNA技术制造。在成人中,用干扰素治疗慢性丙型肝炎,20% - 25%的治疗病例会出现持续反应。初步研究为干扰素用于治疗儿童慢性丙型肝炎提供了令人鼓舞的结果,但需要在更多儿童群体中进行使用该药物的对照试验。

相似文献

1
[Alpha-interferon in the treatment of chronic hepatitis C in children].[α-干扰素治疗儿童慢性丙型肝炎]
Pediatr Med Chir. 1995 Nov-Dec;17(6):501-7.
2
Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.α-干扰素治疗慢性丙型肝炎。临床组织学及病毒学意义。
Rev Esp Enferm Dig. 1997 Jul;89(7):531-50.
3
Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.干扰素-α治疗对慢性丙型肝炎合并炎症性肠病患者是否安全有效?一项病例对照研究。
Aliment Pharmacol Ther. 2005 Aug 1;22(3):209-15. doi: 10.1111/j.1365-2036.2005.02556.x.
4
Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
Arch Immunol Ther Exp (Warsz). 1996;44(5-6):359-66.
5
Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.血液透析患者急性丙型肝炎感染后第一年的α干扰素治疗:疗效与耐受性
Eur J Gastroenterol Hepatol. 2007 Feb;19(2):119-23. doi: 10.1097/01.meg.0000252626.73172.f3.
6
[Cost-effectiveness analysis of the treatment of chronic hepatitis C].[慢性丙型肝炎治疗的成本效益分析]
Gastroenterol Clin Biol. 1996;20(11):958-67.
7
Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.两种不同剂量的α-白细胞干扰素治疗慢性丙型肝炎患者的比较。
Hepatogastroenterology. 1997 Jul-Aug;44(16):1182-6.
8
Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
Rev Esp Enferm Dig. 1997 Jul;89(7):523-30.
9
Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.慢性丙型肝炎四种淋巴母细胞样α干扰素治疗方案的前瞻性比较。预测治疗持续应答因素的多变量分析。
Eur J Gastroenterol Hepatol. 1997 Dec;9(12):1169-77.
10
Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment.一名接受α干扰素治疗的慢性丙型肝炎患者发生乙型肝炎病毒重叠感染。
Hepatogastroenterology. 1995 Apr;42(2):189-91.